The long-term objective O?'f our research is to understand the physiological relevance of sperm membrane lipid composition and factors that modify and perturb it. A factor that has emerged as especially damaging to sperm and a leading cause of defective sperm function is lipid peroxidation. Mechanisms leading to the generation and propagation of lipid peroxides and their damaging effects are documented but less is known about mechanisms to limit the damage once peroxidation has begun. Recent reports demonstrate that membrane phospholipids cleaved during oxidative degradation provide a unique substrate for a special phospholipase A2, PAF acetylhdyrolase (PAF-A-H), which recognizes damaged lipids within the membrane and selectively hydrolyses them, leaving normal phospholipids intact. Upon peroxidative degradation, the ether-linked, polyunsaturated phosphohpids characteristic of mammalian sperm provide the most important substrate for this enzyme. We have determined that the specific activity of PAF-AH in bovine seminal plasma is ca. 40- to 50-fold higher than that reported for any other biological fluid andthat seminal plasma selectively hydrolyses structural analogues of oxidatively fragmented pbospholipids. We propose that this enzyme plays an important role in limiting peroxidative damage to sperm, as well as the undesirable release of bioactive lipids with PAF-like activity during sperm transport in the female reproductive tract.
Specific aims of this research project are to:(1) Characterize the molecular species resulting from peroxidative degradation of sperm membrane and their effect on sperm viability; (2) Determine the substrate specificity of oxidatively damaged sperm PLs for PAF-AH; (3) Characterize the production of PAF-AH in seminal plasma andits relationship to sperm function and fertility; and (4) Purify PAF-AH from seminal plasma to characterize further its effects on sperm membrane structure and function.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
5P41RR010888-05
Application #
6345235
Study Section
Project Start
2000-07-01
Project End
2002-06-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
5
Fiscal Year
2000
Total Cost
$2,519
Indirect Cost
Name
Boston University
Department
Type
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Lu, Yanyan; Jiang, Yan; Prokaeva, Tatiana et al. (2017) Oxidative Post-Translational Modifications of an Amyloidogenic Immunoglobulin Light Chain Protein. Int J Mass Spectrom 416:71-79
Sethi, Manveen K; Zaia, Joseph (2017) Extracellular matrix proteomics in schizophrenia and Alzheimer's disease. Anal Bioanal Chem 409:379-394
Hu, Han; Khatri, Kshitij; Zaia, Joseph (2017) Algorithms and design strategies towards automated glycoproteomics analysis. Mass Spectrom Rev 36:475-498
Ji, Yuhuan; Bachschmid, Markus M; Costello, Catherine E et al. (2016) S- to N-Palmitoyl Transfer During Proteomic Sample Preparation. J Am Soc Mass Spectrom 27:677-85
Hu, Han; Khatri, Kshitij; Klein, Joshua et al. (2016) A review of methods for interpretation of glycopeptide tandem mass spectral data. Glycoconj J 33:285-96
Pu, Yi; Ridgeway, Mark E; Glaskin, Rebecca S et al. (2016) Separation and Identification of Isomeric Glycans by Selected Accumulation-Trapped Ion Mobility Spectrometry-Electron Activated Dissociation Tandem Mass Spectrometry. Anal Chem 88:3440-3
Wang, Yun Hwa Walter; Meyer, Rosana D; Bondzie, Philip A et al. (2016) IGPR-1 Is Required for Endothelial Cell-Cell Adhesion and Barrier Function. J Mol Biol 428:5019-5033
Srinivasan, Srimathi; Chitalia, Vipul; Meyer, Rosana D et al. (2015) Hypoxia-induced expression of phosducin-like 3 regulates expression of VEGFR-2 and promotes angiogenesis. Angiogenesis 18:449-62
Yu, Xiang; Sargaeva, Nadezda P; Thompson, Christopher J et al. (2015) In-Source Decay Characterization of Isoaspartate and ?-Peptides. Int J Mass Spectrom 390:101-109
Steinhorn, Benjamin S; Loscalzo, Joseph; Michel, Thomas (2015) Nitroglycerin and Nitric Oxide--A Rondo of Themes in Cardiovascular Therapeutics. N Engl J Med 373:277-80

Showing the most recent 10 out of 253 publications